Integral Diagnostics Ltd (IDX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.074x

Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has a cash flow conversion efficiency ratio of 0.074x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$51.60 Million ≈ $36.51 Million USD) by net assets (AU$693.94 Million ≈ $491.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Integral Diagnostics Ltd to measure how much of total assets are equity-financed.

Integral Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Integral Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Integral Diagnostics Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Integral Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integral Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gloria Material Technology TWO:5009	0.023x
Guangdong Xiongsu Technology Group Co Ltd SHE:300599	0.001x
Relx PLC LSE:REL	0.608x
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	0.105x
TOMTOM N.V.ADRS 1/2 EO-20 F:OEMB	0.065x
BELL AGROMACHINA ORD T (BSE) NSE:BALUFORGE	0.032x
Stendörren Fastigheter AB (publ) ST:STEF-B	0.020x
Gan Yuan Foods Co Ltd SHE:002991	0.067x

Annual Cash Flow Conversion Efficiency for Integral Diagnostics Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Integral Diagnostics Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Integral Diagnostics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$693.94 Million ≈ $491.01 Million	AU$73.77 Million ≈ $52.20 Million	0.106x	-51.52%
2024-06-30	AU$301.71 Million ≈ $213.48 Million	AU$66.16 Million ≈ $46.81 Million	0.219x	+14.54%
2023-06-30	AU$373.05 Million ≈ $263.96 Million	AU$71.42 Million ≈ $50.53 Million	0.191x	+79.19%
2022-06-30	AU$347.24 Million ≈ $245.70 Million	AU$37.10 Million ≈ $26.25 Million	0.107x	-60.88%
2021-06-30	AU$254.74 Million ≈ $180.24 Million	AU$69.57 Million ≈ $49.23 Million	0.273x	+14.95%
2020-06-30	AU$228.33 Million ≈ $161.56 Million	AU$54.25 Million ≈ $38.39 Million	0.238x	-10.90%
2019-06-30	AU$127.22 Million ≈ $90.02 Million	AU$33.92 Million ≈ $24.00 Million	0.267x	-6.06%
2018-06-30	AU$93.42 Million ≈ $66.10 Million	AU$26.52 Million ≈ $18.76 Million	0.284x	+12.83%
2017-06-30	AU$90.35 Million ≈ $63.93 Million	AU$22.73 Million ≈ $16.08 Million	0.252x	-12.23%
2016-06-30	AU$83.92 Million ≈ $59.38 Million	AU$24.05 Million ≈ $17.02 Million	0.287x	-29.91%
2015-06-30	AU$41.84 Million ≈ $29.60 Million	AU$17.11 Million ≈ $12.11 Million	0.409x	-67.85%
2014-06-30	AU$2.90 Million ≈ $2.06 Million	AU$3.70 Million ≈ $2.61 Million	1.272x	-13.56%
2013-06-30	AU$2.54 Million ≈ $1.80 Million	AU$3.74 Million ≈ $2.65 Million	1.472x	+55.94%
2012-06-30	AU$2.54 Million ≈ $1.80 Million	AU$2.40 Million ≈ $1.70 Million	0.944x	--

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$585.79 Million

AU$827.90 Million AUD

Market Cap Rank

#11407 Global

#301 in Australia

Share Price

AU$2.22

Change (1 day)

+0.00%

52-Week Range

AU$1.94 - AU$3.05

All Time High

AU$5.00